TCL Archive MGI Pharma’s Irofulven In Phase III Trial Vs. 5-FU For Advanced Pancreatic Cancer. March 2, 2001
TCL Archive Guest Editorial: Once Again, Hype Overshadows Data In Breast Cancer Screening Debate February 14, 2014